CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
FUREN Group Pharmaceutical Co Ltd Company Snapshot
FUREN Group Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares FUREN Group Pharmaceutical Co Ltd with three other companies in this sector in China: Guizhou Xinbang Pharmaceutical Company Limited (2018 sales of 6.58 billion Chinese Renmimbi [US$929.14 million] of which 64% was Pharmaceutical industry), Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (6.36 billion Chinese Renmimbi [US$897.84 million] of which 66% was Chinese Medicine), and Zhejiang Conba Pharmaceutical Co., Ltd. (6.78 billion Chinese Renmimbi [US$958.04 million] of which 98% was Manufacturing).

Sales Analysis. FUREN Group Pharmaceutical Co Ltd reported sales of 6.32 billion Chinese Renmimbi (US$892.00 million) for the year ending December of 2018. This represents an increase of 8.9% versus 2017, when the company's sales were 5.80 billion Chinese Renmimbi. Sales at FUREN Group Pharmaceutical Co Ltd have increased during each of the previous five years (and since 2013, sales have increased a total of 1,518%). Sales of Other Operations saw an increase that was more than double the company's growth rate: sales were up 1,380.2% in 2018, from 7.12 million Chinese Renmimbi to 105.42 million Chinese Renmimbi. FUREN Group Pharmaceutical Co Ltd also saw significant increases in sales in Pharmaceutical Business (up 37.1% to 1.16 billion Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
FUREN Group Pharmaceutical Co Ltd
  Stock Performance Chart for FUREN Group Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (10/11/2019): 5.41
(Figures in Chinese Renmimbi)
1 Week 0.9%   13 Weeks -3.0%  
4 Weeks -46.1%   52 Weeks -61.6%  
 
FUREN Group Pharmaceutical Co Ltd Key Data:
  Ticker: 600781 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 6,317,313,150
(Year Ending Jan 2019).
Employees: 4,653
  Currency: Chinese Renmimbi Market Cap: 3,392,922,140
  Fiscal Yr Ends: December Shares Outstanding: 627,157,512
  Share Type: A Gu Closely Held Shares: 486,100,629
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.